| 000 | 01821 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515111845.0 | ||
| 264 | 0 | _c20080721 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a0306-4522 | ||
| 024 | 7 |
_a10.1016/j.neuroscience.2007.11.044 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe March, Z | |
| 245 | 0 | 0 |
_aCortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions. _h[electronic resource] |
| 260 |
_bNeuroscience _cMar 2008 |
||
| 300 |
_a734-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xmetabolism |
| 650 | 0 | 4 |
_aCell Communication _xphysiology |
| 650 | 0 | 4 |
_aCell Survival _xphysiology |
| 650 | 0 | 4 |
_aCerebral Cortex _xmetabolism |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aCytoprotection _xphysiology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 |
_aHuntington Disease _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNerve Degeneration _xchemically induced |
| 650 | 0 | 4 | _aNeurotoxins |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aQuinolinic Acid |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUp-Regulation _xphysiology |
| 700 | 1 | _aZuccato, C | |
| 700 | 1 | _aGiampà, C | |
| 700 | 1 | _aPatassini, S | |
| 700 | 1 | _aBari, M | |
| 700 | 1 | _aGasperi, V | |
| 700 | 1 | _aDe Ceballos, M L | |
| 700 | 1 | _aBernardi, G | |
| 700 | 1 | _aMaccarrone, M | |
| 700 | 1 | _aCattaneo, E | |
| 700 | 1 | _aFusco, F R | |
| 773 | 0 |
_tNeuroscience _gvol. 152 _gno. 3 _gp. 734-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroscience.2007.11.044 _zAvailable from publisher's website |
| 999 |
_c17816789 _d17816789 |
||